CHLORIDE TRANSPORT IN PRIMARY CULTURES OF RABBIT COLONOCYTES AT DIFFERENT STAGES OF DEVELOPMENT

Citation
Gn. Desai et al., CHLORIDE TRANSPORT IN PRIMARY CULTURES OF RABBIT COLONOCYTES AT DIFFERENT STAGES OF DEVELOPMENT, Gastroenterology, 111(6), 1996, pp. 1541-1550
Citations number
35
Categorie Soggetti
Gastroenterology & Hepatology
Journal title
ISSN journal
00165085
Volume
111
Issue
6
Year of publication
1996
Pages
1541 - 1550
Database
ISI
SICI code
0016-5085(1996)111:6<1541:CTIPCO>2.0.ZU;2-S
Abstract
Background & Aims: Ontogeny of colonic Cl- transport and its regulatio n has been characterized inadequately. The aim of this report was to s tudy developmental changes in Cl- transport in primary cultures of rab bit distal colonocytes. Methods: Colonocytes from newborn (7-9 days ol d), weanling (25-28 days old), and adult (6 months old) rabbits were c ultured for 24 hours on a collagen IV matrix, and Cl- transport was me asured using the fluoroprobe 6-methoxyquinolyl acetoethyl ester. Resul ts: Cl- permeabilities were dependent on [Cl-](o) with maximal rates ( in millimoles per liter per second) at [Cl-](o) = 75 mmol/L (newborns; 0.15 +/- 0.04; weanlings; 0.2 +/- 0.02; and adults, 0.32 +/- 0.06). I nflux was inhibited significantly by the Cl- channel (50 mu mol/L diph enylamine-2-carboxylate) and the Na+-K+-2Cl(-) cotransport (10 mu mol/ L furosemide) inhibitors. The adenosine 3',5'-cyclic monophosphate (cA MP)-dependent secretagogues, prostaglandin E(1) (1 mu mol/L), forskoli n (1 mu mol/L), and 8-bromo-cAMP (100 mu mol/L), and the protein kinas e 6 activator, phorbol 12-13 dibutyrate (1 mu mol/L), increased Cl- in flux significantly in all groups with adults showing greatest stimulat ion. However, taurodeoxycholate (0.025-1 mmol/L) had an effect only in the adult and the guanosine 3',5'-cyclic monophosphate (cGMP) activat ors STa and 8-bromo-cGMP had no effect. Conclusions: Rabbit distal col onocytes possess inhibitor-sensitive Cl- permeabilities even in neonat es. However, the ontogeny of their regulation depends on the secretago gue-signaling pathway.